According to a new report published by Allied Market Research, titled, โGlobal Multiplex assay Market by type, product, application, end user, and region: Global Opportunity Analysis and Industry Forecast, 2021โ2030,โ The global multiplex assay market size was valued at $1,940.49 million in 2020, and is projected to reach $4,366.32 million by 2030, registering a CAGR of 8.3% from 2021 to 2030.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
The key players in this multiplex assay market have adopted product launch as one of their key developmental strategies such as business expansion and collaboration. The major companies profiled in this report include Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc., Meso Scale Diagnostics LLC, and Randox Laboratories Ltd.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/1921
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- By type, the protein based multiplex assay segment was the highest contributor to the market in 2020 and is expected to continue during the forecast period owing to upsurge in adoption of protein based multiplex assays, and continuously investing in R&D for the introduction of innovative technology.
- By product, the reagents and consumables segment dominated the global Multiplex assay market in 2020. This is attributed to rising demand increasing demand of consumables and the recurring purchase of assays and reagents for increasing research applications.
- Based on application, the research and development segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period owing to wide applications of multiplex assay technologies in research & development functions and convenience and quicker results offered by the multiplex assays while performing assays.
- By end users, the pharmaceutical and biotechnology companies segment dominated the global Multiplex assay market in 2020. This is attributed to rise in penetration of multiplex assays in pharmaceutical and biotechnological companies, as compared to conventional assays, for biomolecules detection, biomarker validation, and measuring the pathways for diseases & physiological activities.
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
The outbreak of COVID-19 has disrupted workflows in the health care sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The overall impact of the COVID-19 pandemic remained positive for key players in the multiplex assay industry. As multiplex assays are been used for covid diagnosis, there has been a massive demand of multiplex of the SARS-CoV-2 assay such as multiplex point-of-care assays is positively boosting the growth of the multiplex assay market during the pandemic. Several companies received the FDA emergency use authorization for their COVID-19 multiplex assays to meet the soaring demand of the high volume of testing.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/1921
Multiplex assays are techniques in which multiple analytes are analyzed simultaneously, and hence are economical and easily controlled in any sample assay. These assays enable extraction of more data from a sample in the same time as compared to single-plex assays. The major factors which drive the growth of this market include increase in R&D activities for the detection biomarkers for various diseases & treatment options of diseases, rise in adoption of personalized medicine for increasing safety & efficacy of therapies, and benefits such as lower operational cost & reduced labor. However, dearth of skilled labor and high capital investment are anticipated to restrain the multiplex assay market growth during the forecast period.
The major factors driving the growth of the multiplex assay market include increased incidence of chronic diseases, rising acceptance of personalized treatment, numerous advances of multiplex assays over traditional assays. Moreover, rise in research activities in the pharmaceutical and biotechnological sectors, increased government funding is creating lucrative opportunities for the multiplex assay market. However, high prices of procurement and usage of multiplex assays are causing restrain in the market growth.
Rising health awareness among the individuals, growing adoption of companion diagnostics for increasing the safety and efficacy of therapies and rising medical tourism fuel the growth of the market.
๐๐ฒ๐ ๐๐ฒ๐๐ฎ๐ถ๐น๐ฒ๐ฑ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/multiplex-assays-market
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com